Solis Pharma US, Inc.

SEC insider activity covers quarterly filings through June 30, 2026. Later filings are not included. Reported roles do not establish current employment or current holdings. SEC filing documents, sections and filing-text search cover filings dated January 1, 2000 onward. Earlier filings are deferred until after launch.

organization

SEC Insider

$28.81B

4 transactions

Summary

Solis Pharma US, Inc. is an organization.

Recent Insider Transactions

As filed, including amendments; not net cash flow or current holdings. Joint reports count once. Totals cover known values only.

Buys: —Sales: $28.81B4 insiders

Date	Insider	Type	Value
2013-09-30	CASSIDY JAMES M	Sell	$9.60B
2013-09-30	Tiber Creek CORP	Sell	$9.60B
2013-09-30	McKillop James K	Sell	$9.60B
2013-09-30	MB Americus LLC	Sell	$10K

SEC filings: SEC EDGAR

Activity data: SEC EDGAR

Solis Pharma US, Inc. — Contributions, Lobbying & Contracts | Poliscope